Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Low Nicotine Cigarette Messaging
NCT04740008Phase 1Completed
- Sponsor
- Masonic Cancer Center
- Start
- Apr 2021
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 1, randomised trial (2 arms), sponsored by Masonic Cancer Center. Primary endpoint: Proportion of participants that choose ANDS or no tobacco at 17 days. Started Apr 2021; status: completed.
Beyond the preview
Go deeper on NCT04740008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04740008.